Met Life Investment Management, LLC Allogene Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 38,020 shares of ALLO stock, worth $74,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,020
Previous 53,147 28.46%
Holding current value
$74,139
Previous $148,000 45.95%
% of portfolio
0.0%
Previous 0.0%

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$1.84 - $3.22 $27,833 - $48,708
-15,127 Reduced 28.46%
38,020 $80,000
Q3 2024

Nov 13, 2024
SELL
$2.08 - $3.5 $12,465 - $20,975
-5,993 Reduced 10.13%
53,147 $148,000
Q2 2024

Aug 13, 2024
BUY
$2.23 - $4.38 $22,612 - $44,413
10,140 Added 20.69%
59,140 $137,000
Q1 2024

May 14, 2024
BUY
$2.92 - $5.63 $143,080 - $275,870
49,000 New
49,000 $219,000
Q2 2023

Apr 29, 2024
BUY
$4.53 - $6.74 $190,341 - $283,201
42,018 New
42,018 $208,000
Q1 2023

May 09, 2024
BUY
$4.92 - $8.21 $206,728 - $344,967
42,018 New
42,018 $208 Million
Q3 2022

May 10, 2024
BUY
$10.32 - $17.28 $17,213 - $28,823
1,668 Added 4.13%
42,018 $453,000
Q3 2022

Mar 22, 2023
BUY
$10.32 - $17.28 $17,213 - $28,823
1,668 Added 4.13%
42,018 $453,000
Q3 2022

Nov 14, 2022
BUY
$10.32 - $17.28 $17,213 - $28,823
1,668 Added 4.13%
42,018 $454,000
Q2 2022

May 10, 2024
BUY
$6.78 - $12.28 $27,282 - $49,414
4,024 Added 11.08%
40,350 $459,000
Q2 2022

Jun 20, 2023
SELL
$6.78 - $12.28 $11,309 - $20,483
-1,668 Reduced 3.97%
40,350 $459,000
Q2 2022

Mar 22, 2023
BUY
$6.78 - $12.28 $27,282 - $49,414
4,024 Added 11.08%
40,350 $459,000
Q2 2022

Aug 11, 2022
BUY
$6.78 - $12.28 $27,282 - $49,414
4,024 Added 11.08%
40,350 $460,000
Q1 2022

May 10, 2024
BUY
$7.65 - $15.29 $277,893 - $555,424
36,326 New
36,326 $330,000
Q1 2022

Jun 20, 2023
SELL
$7.65 - $15.29 $43,543 - $87,030
-5,692 Reduced 13.55%
36,326 $330,000
Q1 2022

Mar 22, 2023
BUY
$7.65 - $15.29 $102,655 - $205,176
13,419 Added 58.58%
36,326 $330,000
Q1 2022

May 12, 2022
BUY
$7.65 - $15.29 $102,655 - $205,176
13,419 Added 58.58%
36,326 $331,000
Q4 2021

Jun 21, 2023
SELL
$13.13 - $24.52 $250,927 - $468,601
-19,111 Reduced 45.48%
22,907 $341,000
Q3 2021

Jun 21, 2023
SELL
$21.01 - $27.64 $401,522 - $528,228
-19,111 Reduced 45.48%
22,907 $588,000
Q2 2021

Jun 21, 2023
SELL
$23.49 - $35.8 $448,917 - $684,173
-19,111 Reduced 45.48%
22,907 $597,000
Q1 2021

May 17, 2024
SELL
$25.79 - $39.02 $672,938 - $1.02 Million
-26,093 Reduced 53.25%
22,907 $808,000
Q1 2021

Jun 26, 2023
SELL
$25.79 - $39.02 $492,872 - $745,711
-19,111 Reduced 45.48%
22,907 $809 Million
Q4 2020

Jun 22, 2023
SELL
$25.24 - $43.45 $482,361 - $830,372
-19,111 Reduced 45.48%
22,907 $578,000
Q3 2020

May 24, 2024
BUY
$32.38 - $44.96 $43,745 - $60,740
1,351 Added 6.27%
22,907 $864 Million
Q3 2020

Jun 26, 2023
SELL
$32.38 - $44.96 $618,814 - $859,230
-19,111 Reduced 45.48%
22,907 $863,000
Q3 2020

Mar 22, 2023
BUY
$32.38 - $44.96 $43,745 - $60,740
1,351 Added 6.27%
22,907 $863,000
Q3 2020

Nov 13, 2020
BUY
$32.38 - $44.96 $43,745 - $60,740
1,351 Added 6.27%
22,907 $864,000
Q2 2020

May 24, 2024
SELL
$18.39 - $54.04 $504,695 - $1.48 Million
-27,444 Reduced 56.01%
21,556 $923 Million
Q2 2020

Jun 26, 2023
SELL
$18.39 - $54.04 $376,296 - $1.11 Million
-20,462 Reduced 48.7%
21,556 $923,000
Q2 2020

Mar 22, 2023
BUY
$18.39 - $54.04 $65,229 - $191,679
3,547 Added 19.7%
21,556 $923,000
Q2 2020

Aug 14, 2020
BUY
$18.39 - $54.04 $65,229 - $191,679
3,547 Added 19.7%
21,556 $923,000
Q1 2020

Jul 12, 2023
SELL
$18.22 - $28.25 $437,443 - $678,254
-24,009 Reduced 57.14%
18,009 $350,000
Q4 2019

Jul 12, 2023
SELL
$24.82 - $31.4 $595,903 - $753,882
-24,009 Reduced 57.14%
18,009 $467,000
Q3 2019

Jul 12, 2023
SELL
$26.11 - $32.99 $626,874 - $792,056
-24,009 Reduced 57.14%
18,009 $490,000
Q3 2019

Mar 22, 2023
BUY
$26.11 - $32.99 $140,289 - $177,255
5,373 Added 42.52%
18,009 $490,000
Q3 2019

Nov 14, 2019
BUY
$26.11 - $32.99 $140,289 - $177,255
5,373 Added 42.52%
18,009 $491,000
Q2 2019

Jul 12, 2023
SELL
$25.56 - $31.09 $613,670 - $746,439
-24,009 Reduced 57.14%
18,009 $483,000
Q1 2019

Jul 13, 2023
SELL
$24.82 - $32.54 $729,261 - $956,090
-29,382 Reduced 69.93%
12,636 $365,000
Q4 2018

Jul 13, 2023
SELL
$22.5 - $33.3 $661,095 - $978,420
-29,382 Reduced 69.93%
12,636 $340,000
Q4 2018

Mar 22, 2023
SELL
$22.5 - $33.3 $661,095 - $978,420
-29,382 Reduced 69.93%
12,636 $340,000
Q4 2018

Feb 14, 2019
BUY
$22.5 - $33.3 $284,310 - $420,778
12,636 New
12,636 $340,000

Others Institutions Holding ALLO

# of Institutions
177
Shares Held
139M
Call Options Held
75.8K
Put Options Held
52.8K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $280M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email